Please use this identifier to cite or link to this item:
Main Title: Hepatitis E virus superinfection and clinical progression in hepatitis B patients
Author(s): Hoan, Nghiem Xuan
Tong, Hoang Van
Hecht, Nicole
Sy, Bui Tien
Marcinek, Patrick
Meyer, Christian G.
Song, Le Huu
Toan, Nguyen Linh
Kurreck, Jens
Kremsner, Peter G.
Bock, C-Thomas
Velavan, Thirumalaisamy P.
Type: Article
Language Code: en
Abstract: Hepatitis E virus (HEV) infection may cause acute hepatitis and lead to hepatic failure in developing and developed countries. We studied HEV seroprevalences in patients with hepatitis B virus (HBV) infection to understand the consequences of HEV superinfection in a Vietnamese population. This cross-sectional study was conducted from 2012 to 2013 and included 1318 Vietnamese patients with HBV-related liver diseases and 340 healthy controls. The case group included patients with acute (n = 26) and chronic hepatitis B (n = 744), liver cirrhosis (n = 160), hepatocellular carcinoma (n = 166) and patients with both liver cirrhosis and hepatocellular carcinoma (n = 222). Anti-HEV IgG and IgM antibodies were assessed in patients and controls by ELISA. HEV-RNA was identified by PCR assays and sequencing. Seroprevalences of anti-HEV IgG among hepatitis B patients and controls were 45% and 31%, respectively (adjusted P = 0.034). Anti-HEV IgM seroprevalences were 11.6% and 4.7% in patients and controls, respectively (adjusted P = 0.005). Seroprevalences were higher among the elder individuals. When stratifying for patient groups, those with liver cirrhosis had the highest anti-HEV IgG (52%) and anti-HEV IgM (19%) seroprevalences. Hepatitis B patients with current HEV infection had abnormal liver function tests compared to patients with past or without HEV infection. One HEV isolate was retrieved from a patient with both liver cirrhosis and hepatocellular carcinoma and identified as HEV genotype 3. This study indicates high prevalences of HEV infection in Vietnamese HBV patients and among healthy individuals and shows that HEV superinfection may influence the outcome and progression of HBV-related liver disease.
Issue Date: 2015
Date Available: 28-May-2018
DDC Class: 570 Biowissenschaften; Biologie
Subject(s): hepatitis E virus
HEV seroprevalence
HEV superinfection
HBV infection
HBV-related liver diseases
Journal Title: Ebiomedicine
Publisher: Elsevier
Publisher Place: Amsterdam
Volume: 2
Issue: 12
Publisher DOI: 10.1016/j.ebiom.2015.11.020
Page Start: 2080
Page End: 2086
ISSN: 2352-3964
Appears in Collections:FG Angewandte Biochemie » Publications

Files in This Item:
File Description SizeFormat 
1-s2.0-S2352396415302048-main.pdf577.52 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons